IP Library Granted Patent US 8,314,210
Granted Patent B2
US 8,314,210 · App. 10/617,568 · Granted Nov 20, 2012

Compositions and methods for the generation of MHC class II compounds by peptide exchange

Assignee: Dana-Farber Cancer Institute, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,314,210
App. No.
10/617,568
Granted
Nov 20, 2012
Kind
B2
Abstract

The present invention relates to novel compositions and methods for the generation of MHC class II compounds. Such methods are useful in identifying antigen-specific T cells, regulating an immune response and treating subjects suffering from an immune disorder.

Claims (11)

1. An isolated MHC class II compound comprising:

(a) an MHC class II component comprising at least a portion of an MHC class II α chain and at least a portion of an MHC class II α chain, such that said MHC class II α chain and MHC class II α chain form a peptide binding groove;

(b) a spaceholder molecule, wherein said spaceholder molecule:

(1) consists of the amino acid sequence, PVSKMRMATPLLMQA (SEQ ID NO:1), and

(2) is directly linked to a processable linker, wherein the processable linker is linked to said MHC class II component; and

(c) an effector component, wherein said effector component is linked to said MHC class II component.

2. The MHC class II compound of claim 1 , wherein said processable linker is linked to said MHC class II α chain of said MHC class II component.

3. The MHC class II compound of claim 1 , wherein said effector component is linked to said MHC class II α chain of said MHC class II component by a second linker.

4. The MHC class II compound of claim 1 , wherein said effector component is selected from the group consisting of a fluorescent label, biotin, at least part a portion of an immunoglobulin protein, a metallic compound, luciferin, a radiolabel, a cytokine, a viral capsid protein and an enzyme.

5. The method of claim 4 , wherein said effector component is biotin.

6. The MHC class II compound of claim 1 , wherein said MHC class II compound is encoded by a nucleic acid molecule, and wherein said nucleic acid molecule comprises a nucleic acid sequence encoding a signal segment attached to the N-terminus of said MHC class II component.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 8, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039601/0425 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2003
From: WUCHERPFENNIG, KAI W.; SETH NILUFER
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 014678/0688 →
Continuity (3)
Provisional Application 60395494 · Jul 12, 2002
Provisional Application 60397893 · Jul 22, 2002
Related Publication 20040197862A1 · Oct 7, 2004